Guardant Health (NASDAQ: GH) revenue
Guardant Health reported revenue of $982.0m for fiscal 2025, 32.9% more than in fiscal 2024 ($739.0m). Since fiscal 2017 its revenue has grown by 1,870.3%, an average growth of 45.1% a year.
Guardant Health has grown its revenue for 8 years in a row, and fiscal 2025 is the highest of its 9 fiscal years on record.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $982.0m | +32.9% | −$437.2m | −44.5% |
| 2024 | $739.0m | +31.0% | −$443.6m | −60.0% |
| 2023 | $563.9m | +25.5% | −$564.7m | −100.1% |
| 2022 | $449.5m | +20.3% | −$544.4m | −121.1% |
| 2021 | $373.7m | +30.3% | −$411.0m | −110.0% |
| 2020 | $286.7m | +33.8% | −$255.0m | −88.9% |
| 2019 | $214.4m | +136.5% | −$82.4m | −38.4% |
| 2018 | $90.6m | +81.9% | −$92.9m | −102.5% |
| 2017 | $49.8m | — | −$76.6m | −153.7% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Guardant Health revenue compared with its sector
By revenue for its latest fiscal year, Guardant Health ranks 150th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Guardant Health, 32.9%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 148th | Tandem Diabetes Care | $1,015m | 7.9% |
| 149th | InnovAge | $989.7m | 15.9% |
| 150th | Guardant Health | $982.0m | 32.9% |
| 151st | Claritev | $965.4m | 3.7% |
| 152nd | Madrigal Pharmaceuticals | $958.4m | 432.1% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Guardant Health
- How much revenue did Guardant Health make in fiscal 2025?
- Guardant Health reported revenue of $982.0m for fiscal 2025, compared with $739.0m in fiscal 2024.
- How much has the revenue of Guardant Health grown?
- Between fiscal 2017 and fiscal 2025 it went from $49.8m to $982.0m: 1,870.3% more, an average growth of 45.1% a year.
- What was the best year for revenue at Guardant Health?
- Of its last 9 fiscal years, fiscal 2025, with $982.0m.
- Where does Guardant Health rank in its sector by revenue?
- It ranks 150th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Guardant Health come from?
- From the annual report (Form 10-K) that Guardant Health files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Guardant Health files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017. More on Guardant Health: the Guardant Health page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.